Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
32.80
+0.01 (0.03%)
At close: Mar 26, 2026, 4:00 PM EDT
33.11
+0.31 (0.95%)
After-hours: Mar 26, 2026, 7:23 PM EDT
Veracyte Employees
Veracyte had 755 employees as of December 31, 2025. The number of employees decreased by 69 or -8.37% compared to the previous year.
Employees
755
Change (1Y)
-69
Growth (1Y)
-8.37%
Revenue / Employee
$684,960
Profits / Employee
$87,885
Market Cap
2.61B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 755 | -69 | -8.37% |
| Dec 31, 2024 | 824 | 9 | 1.10% |
| Dec 31, 2023 | 815 | 28 | 3.56% |
| Dec 31, 2022 | 787 | 26 | 3.42% |
| Dec 31, 2021 | 761 | 441 | 137.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ICON Public Limited Company | 41,900 |
| Charles River Laboratories International | 19,700 |
| RadNet | 9,276 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
VCYT News
- 10 days ago - Veracyte Names Kevin Haas as Chief Development and Technology Officer - Business Wire
- 4 weeks ago - Artisan Global Discovery Fund Q4 2025 Winners, Laggards, Buys & Sells - Seeking Alpha
- 4 weeks ago - Veracyte, Inc. (VCYT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Veracyte Announces Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 4 weeks ago - Veracyte to Highlight Extensive Decipher® Data at 2026 ASCO GU Symposium - Business Wire
- 5 weeks ago - Veracyte to Participate in Upcoming Investor Conferences - Business Wire
- 7 weeks ago - Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 - Business Wire
- 2 months ago - Veracyte: Profitable, De-Risked, And Ready To Run - Seeking Alpha